<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "1: caution readers", fill: "#c72c48"},
{source: "1: caution readers", target: "1: following important factors among others could", fill: "#c72c48"},
{source: "1: following important factors among others could", target: "1: financial condition", fill: "#c72c48"},
{source: "1: financial condition", target: "1: materially", fill: "#c72c48"},
{source: "1: caution readers", target: "19: evaluate each", fill: "#ff6961"},
{source: "19: evaluate each", target: "19: qualification", fill: "#ff6961"},
{source: "19: qualification", target: "19: firm backlog there", fill: "#ff6961"},
{source: "19: firm backlog there", target: "19: backlog ultimately will", fill: "#ff6961"},
{source: "19: backlog ultimately will", target: "19: future revenue", fill: "#ff6961"},
{source: "19: evaluate each", target: "21: uncertain economic environment", fill: "#645452"},
{source: "21: uncertain economic environment", target: "21: adversely affect", fill: "#645452"},
{source: "21: adversely affect", target: "21: operations", fill: "#645452"},
{source: "21: uncertain economic environment", target: "40: decisions", fill: "#860111"},
{source: "40: decisions", target: "40: indemnification", fill: "#860111"},
{source: "40: indemnification", target: "40: agreement", fill: "#860111"},
{source: "40: agreement", target: "40: agreement may", fill: "#860111"},
{source: "40: decisions", target: "61: Our Agilent ", fill: "#cfcfc4"},
{source: "61: Our Agilent ", target: "61: supply agreement allows", fill: "#cfcfc4"},
{source: "61: supply agreement allows", target: "61: manufacture", fill: "#cfcfc4"},
{source: "61: manufacture", target: "61: technology", fill: "#cfcfc4"},
{source: "61: Our Agilent ", target: "83: significantly smaller than", fill: "#fffff0"},
{source: "83: significantly smaller than", target: "83: competitors", fill: "#fffff0"},
{source: "83: competitors", target: "83: financial resources", fill: "#fffff0"},
{source: "83: financial resources", target: "83: future revenue", fill: "#fffff0"},
{source: "83: significantly smaller than", target: "94: licensees may", fill: "#b31b1b"},
{source: "94: licensees may", target: "94: detract attention", fill: "#b31b1b"},
{source: "94: detract attention", target: "94: introduction", fill: "#b31b1b"},
{source: "94: introduction", target: "94: products using", fill: "#b31b1b"},
{source: "94: products using", target: "94: technology", fill: "#b31b1b"},
{source: "94: licensees may", target: "96: license agreements", fill: "#ace5ee"},
{source: "96: license agreements", target: "96: agreements", fill: "#ace5ee"},
{source: "96: agreements", target: "96: royalty limits which", fill: "#ace5ee"},
{source: "96: royalty limits which", target: "96: derive under", fill: "#ace5ee"},
{source: "96: license agreements", target: "105: Potential ", fill: "#e8000d"},
{source: "105: Potential ", target: "105: intellectual", fill: "#e8000d"},
{source: "105: intellectual", target: "105: property might", fill: "#e8000d"},
{source: "105: property might", target: "105: interested unless", fill: "#e8000d"},
{source: "105: interested unless", target: "105: commercial viability", fill: "#e8000d"},
{source: "105: commercial viability", target: "105: technology", fill: "#e8000d"},
{source: "105: technology", target: "105: demonstrated", fill: "#e8000d"},
{source: "105: Potential ", target: "START_HERE", fill: "#e8000d"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Food Distributors</td>
    </tr>
    <tr>
      <td>Trading Companies and Distributors</td>
    </tr>
    <tr>
      <td>Automobile Manufacturers</td>
    </tr>
    <tr>
      <td>Motorcycle Manufacturers</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Oil and Gas Exploration and Production</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Cooperate</td>
    </tr>
    <tr>
      <td>Political reform</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Leadership</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Grant</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Reward</td>
    </tr>
    <tr>
      <td>Endorse</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Promise</td>
    </tr>
    <tr>
      <td>Psychological state</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Threaten</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Acknowledge responsibility</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_condition_report">Financial condition report</a></td>
      <td>In accounting, a financial condition report (FCR) is a report on the solvency condition of an insurance company that takes into account both the current financial status, as reflected in the balance sheet, and an assessment of the ability of the company to survive future risk scenarios. Risk assessment in an FCR involves dynamic solvency testing, a type of dynamic financial analysis that simulates management response to risk scenarios, to test whether a company could remain solvent in the face of deteriorating economic conditions or major disasters.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Balance_sheet">Balance sheet</a></td>
      <td>In financial accounting, a balance sheet (also known as statement of financial position or statement of financial condition) is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity. Assets, liabilities and ownership equity are listed as of a specific date, such as the end of its financial year.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_ratio">Financial ratio</a></td>
      <td>A financial ratio or accounting ratio is a relative magnitude of two selected numerical values taken from an enterprise's financial statements. Often used in accounting, there are many standard ratios used to try to evaluate the overall financial condition of a corporation or other organization.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_law">Financial law</a></td>
      <td>Financial law is the law and regulation of the insurance, derivatives, commercial banking, capital markets and investment management sectors. Understanding Financial law is crucial to appreciating the creation and formation of banking and financial regulation, as well as the legal framework for finance generally.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Trustmark_(bank)">Trustmark (bank)</a></td>
      <td>Trustmark is a commercial bank and financial services company headquartered in Jackson, Mississippi, United States, with subsidiaries Trustmark National Bank, Trustmark Investment Advisors, and Fisher Brown Bottrell Insurance. The bank's initial predecessor, The Jackson Bank, was chartered by the State of Mississippi in 1889.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_analysis">Financial analysis</a></td>
      <td>Financial analysis (also referred to as financial statement analysis or accounting analysis or Analysis of finance) refers to an assessment of the viability, stability, and profitability of a business, sub-business or project. \nIt is performed by professionals who prepare reports using ratios and other techniques, that make use of information taken from financial statements and other reports.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Form_10-K">Form 10-K</a></td>
      <td>A Form 10-K is an annual report required by the U.S. Securities and Exchange Commission (SEC), that gives a comprehensive summary of a company's financial performance. Although similarly named, the annual report on Form 10-K is distinct from the often glossy "annual report to shareholders," which a company must send to its shareholders when it holds an annual meeting to elect directors (though some companies combine the annual report and the 10-K into one document).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Federal_takeover_of_Fannie_Mae_and_Freddie_Mac">Federal takeover of Fannie Mae and Freddie Mac</a></td>
      <td>In September 2008 the Federal Housing Finance Agency (FHFA) announced that it would take over the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac). Both government-sponsored enterprises, which finance home mortgages in the United States by issuing bonds, had become illiquid as the market for those bonds collapsed in the subprime mortgage crisis.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bitwise_operation">Bitwise operation</a></td>
      <td>In computer programming, a bitwise operation operates on a bit string, a bit array or a binary numeral (considered as a bit string) at the level of its individual bits. It is a fast and simple action, basic to the higher-level arithmetic operations and directly supported by the processor.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_Activities_Center">Special Activities Center</a></td>
      <td>The Special Activities Center (SAC) is a division of the Central Intelligence Agency responsible for covert operations and paramilitary operations. The unit was named Special Activities Division (SAD) prior to 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emergency_operations_center">Emergency operations center</a></td>
      <td>An emergency operations center (EOC) is a central command and control facility responsible for carrying out the principles of emergency preparedness and emergency management, or disaster management functions at a strategic level during an emergency, and ensuring the continuity of operation of a company, political subdivision or other organization.\nAn EOC is responsible for strategic direction and operational decisions and does not normally directly control field assets, instead leaving tactical decisions to lower commands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Surgery">Surgery</a></td>
      <td>Surgery is a medical or dental specialty that uses operative manual and instrumental techniques on a person to investigate or treat a pathological condition such as a disease or injury, to help improve bodily function, appearance, or to repair unwanted ruptured areas.\nThe act of performing surgery may be called a surgical procedure, operation, or simply "surgery".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_(mathematics)">Operation (mathematics)</a></td>
      <td>In mathematics, an operation is a function which takes zero or more input values (called operands) to a well-defined output value. The number of operands (also known as arguments) is the arity of the operation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/TRIPS_Agreement">TRIPS Agreement</a></td>
      <td>The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is an international legal agreement between all the member nations of the World Trade Organization (WTO). It establishes minimum standards for the regulation by national governments of different forms of intellectual property (IP) as applied to nationals of other WTO member nations.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Non-disclosure_agreement">Non-disclosure agreement</a></td>
      <td>A non-disclosure agreement (NDA), also known as a confidentiality agreement (CA), confidential disclosure agreement (CDA), proprietary information agreement (PIA), secrecy agreement (SA), or non-disparagement agreement, is a legal contract or part of a contract between at least two parties that outlines confidential material, knowledge, or information that the parties wish to share with one another for certain purposes, but wish to restrict access to. Doctor–patient confidentiality (physician–patient privilege), attorney–client privilege, priest–penitent privilege and bank–client confidentiality agreements are examples of NDAs, which are often not enshrined in a written contract between the parties.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Technology">Technology</a></td>
      <td>Technology is the result of accumulated knowledge and application of skills, methods, and processes used in industrial production and scientific research. Technology is embedded in the operation of all machines, with or without detailed knowledge of their function, for the intended purpose of an organization.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Technology_company">Technology company</a></td>
      <td>A technology company (or tech company) is an electronics-based technological company, including, for example, business relating to digital electronics, software, and internet-related services, such as e-commerce services.\n\n\n== Details ==\nAccording to Fortune, as of 2020, the ten largest technology companies by revenue are: Apple Inc., Samsung, Foxconn, Alphabet Inc., Microsoft, Huawei, Dell Technologies, Hitachi, IBM, and Sony.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_technology">Financial technology</a></td>
      <td>Financial technology (abbreviated fintech or FinTech) is the technology and innovation that aims to compete with traditional financial methods in the delivery of financial services. Artificial intelligence, Blockchain, Cloud computing, and big Data are regarded as the "ABCD" (four key areas) of FinTech.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Language_technology">Language technology</a></td>
      <td>Language technology, often called human language technology (HLT), studies methods of how computer programs or electronic devices can analyze, produce, modify or respond to human texts and speech. Working with language technology often requires broad knowledge not only about linguistics but also about computer science.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Space_technology">Space technology</a></td>
      <td>Space technology is technology for use in outer space, in travel (astronautics) or other activities beyond Earth's atmosphere, for purposes such as spaceflight, space exploration, and Earth observation. Space technology includes space vehicles such as spacecraft, satellites, space stations and orbital launch vehicles; deep-space communication; in-space propulsion; and a wide variety of other technologies including support infrastructure equipment, and procedures.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Information_technology_consulting">Information technology consulting</a></td>
      <td>In management, information technology consulting (also called IT consulting, computer consultancy, business and technology services, computing consultancy, technology consulting, and IT advisory) is a field of activity which focuses on advising organizations on how best to use information technology (IT) in achieving their business objectives.\nOnce a business owner defines the needs to take a business to the next level, a decision maker will define a scope, cost and a time frame of the project.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Competition">Competition</a></td>
      <td>Competition is a rivalry where two or more parties strive for a common goal which cannot be shared: where one's gain is the other's loss (an example of which is a zero-sum game). Competition can arise between entities such as organisms, individuals, economic and social groups, etc.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Competitor_analysis">Competitor analysis</a></td>
      <td>Competitive analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors. This analysis provides both an offensive and defensive strategic context to identify opportunities and threats.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Competitors_for_the_Crown_of_Scotland">Competitors for the Crown of Scotland</a></td>
      <td>When the crown of Scotland became vacant in September 1290 on the death of the seven-year-old child Queen Margaret, 13 claimants to the throne came forward. Those with the most credible claims were John Balliol, Robert Bruce, John Hastings and Floris V, Count of Holland.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Sport_of_athletics">Sport of athletics</a></td>
      <td>Athletics is a group of sporting events that involves competitive running, jumping, throwing, and walking. The most common types of athletics competitions are track and field, road running, cross country running, and racewalking.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_female_fitness_and_figure_competitors">List of female fitness and figure competitors</a></td>
      <td>This is a list of female fitness and figure competitors.\n\n\n== A ==\nJelena Abbou\n\n\n== B ==\nLauren Beckham\nAlexandra Béres\nSharon Bruneau\n\n\n== C ==\nNatalie Montgomery-Carroll\nJen Cassetty\nKim Chizevsky\nSusie Curry\n\n\n== D ==\nDebbie Dobbins\nNicole Duncan\n\n\n== E ==\nJamie Eason\nAlexis Ellis\n\n\n== F ==\nAmy Fadhli\nJaime Franklin\n\n\n== G ==\nAdela García \nConnie Garner\nElaine Goodlad\nTracey Greenwood\nOksana Grishina\n\n\n== H ==\nMallory Haldeman\nVanda Hădărean\nJen Hendershott\nSoleivi Hernandez\nApril Hunter\n\n\n== I ==\n\n\n== J ==\nTsianina Joelson\n\n\n== K ==\nAdria Montgomery-Klein\nAshley Kaltwasser\n\n\n== L ==\nLauren Lillo\nMary Elizabeth Lado\nTammie Leady\nJennifer Nicole Lee\nAmber Littlejohn\nJulie Lohre\nJenny Lynn\n\n\n== M ==\nTimea Majorová\nLinda Maxwell\nDavana Medina\nJodi Leigh Miller\nChisato Mishima\n\n\n== N ==\nKim Nielsen\n\n\n== O ==\n\n\n== P ==\nVicky Pratt\nElena Panova\nChristine Pomponio-Pate\nCathy Priest\n\n\n== Q ==\n\n\n== R ==\nMaite Richert\nCharlene Rink\nKelly Ryan\n\n\n== S ==\nErin Stern\nCarol Semple-Marzetta\nKrisztina Sereny\nTrish Stratus (Patricia Anne Stratigias)\n\n\n== T ==\nKristi Tauti\nJennifer Thomas\n\n\n== U ==\n\n\n== V ==\nLisa Marie Varon\n\n\n== W ==\nLatisha Wilder\nTorrie Wilson\nLyen Wong\nJenny Worth\nNicole Wilkins\n\n\n== Y ==\n\n\n== Z ==\nMarietta Žigalová\nMalika Zitouni\n\n\n== See also ==\nList of female bodybuilders\n\n\n== References ==\nThere has been a rise in the number of women wanting to compete as fitness models.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_Dancing_with_the_Stars_(American_TV_series)_competitors">List of Dancing with the Stars (American TV series) competitors</a></td>
      <td>Dancing with the Stars is an American reality television show in which celebrity contestants and professional dance partners compete to be the best dancers, as determined by the show's judges and public voting. The series first broadcast in 2005, and thirty complete seasons have aired on ABC. During each season, competitors are progressively eliminated on the basis of public voting and scores received from the judges until only a few contestants remain.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Competitor_Group">Competitor Group</a></td>
      <td>Competitor Group, Inc. (CGI) is a privately held, for-profit, sports marketing and management company based in Mira Mesa, San Diego, California.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Round-robin_tournament">Round-robin tournament</a></td>
      <td>A round-robin tournament (or all-play-all tournament) is a competition in which each contestant meets every other participant, usually in turn. A round-robin contrasts with an elimination tournament, in which participants are eliminated after a certain number of losses.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/License">License</a></td>
      <td>A license (or licence in British English) is an official permission or permit to do, use, or own something (as well as the document of that permission or permit).A license is granted by a party (licensor) to another party (licensee) as an element of an agreement between those parties. In the case of a license issued by a government, the license is obtained by applying for it.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/End-user_license_agreement">End-user license agreement</a></td>
      <td>An end-user license agreement (short EULA) is a legal contract entered into between a software developer or vendor and the user of the software, often where the software has been purchased by the user from an intermediary such as a retailer. A EULA specifies in detail the rights and restrictions which apply to the use of the software.Many form contracts are only contained in digital form and only presented to a user as a click-through which the user must "accept".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Intellectual">Intellectual</a></td>
      <td>An intellectual is a person who engages in critical thinking, research, and reflection about the reality of society, and who proposes solutions for the normative problems of society. Coming from the world of culture, either as a creator or as a mediator, the intellectual participates in politics, either to defend a concrete proposition or to denounce an injustice, usually by either rejecting or producing or extending an ideology, and by defending a system of values.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Intellectualism">Intellectualism</a></td>
      <td>Intellectualism is the mental perspective that emphasizes the use, the development, and the exercise of the intellect; and also identifies the life of the mind of the intellectual person. In the field of philosophy, "intellectualism" is synonymous with rationalism, knowledge derived from reason.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Intellectual_virtue">Intellectual virtue</a></td>
      <td>Intellectual virtues are qualities of mind and character that promote intellectual flourishing, critical thinking, and the pursuit of truth. They include: intellectual responsibility, perseverance, open-mindedness, empathy, integrity, intellectual courage, confidence in reason, love of truth, intellectual humility, imaginativeness, curiosity, fair-mindedness, and autonomy.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Intellectual_giftedness">Intellectual giftedness</a></td>
      <td>Intellectual giftedness is an intellectual ability significantly higher than average. It is a characteristic of children, variously defined, that motivates differences in school programming.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>NVE CORP /NEW/      ITEM 1A RISK FACTORS         We <font color="blue">caution readers</font> that the following important factors, among others, could     affect our <font color="blue">financial condition</font>, operating results, business prospects or any     other aspect of NVE, and could cause our actual results to differ <font color="blue">materially</font>     from that projected or estimated by us in the forward-looking statements     made by us or on our behalf</td>
    </tr>
    <tr>
      <td>Although we have attempted to list below the     important factors which do or may affect our <font color="blue">financial condition</font>, operating     results, business prospects or any other aspect of NVE, other <font color="blue">factors may</font> in     the future prove to be more important</td>
    </tr>
    <tr>
      <td>New <font color="blue">factors emerge from</font> time to time     and it is not possible for us to predict all of <font color="blue">such factors</font></td>
    </tr>
    <tr>
      <td>Similarly, we     <font color="blue">cannot necessarily assess</font> or quantify the impact of each such factor on the     business or the extent to which any factor, or <font color="blue">combination</font> of factors, may     cause  actual  results  to  differ  <font color="blue">materially</font> from those contained in     forward-looking statements</td>
    </tr>
    <tr>
      <td>Risks Related to Our Business         We <font color="blue">may <font color="blue">lose revenue</font></font> if any of our large customers cancel, postpone, or     reduce their purchases</td>
    </tr>
    <tr>
      <td>We <font color="blue">rely on several</font> large customers for a large percentage of our revenue;     these  include <font color="blue">Avago Technologies </font>(the company comprised of the former     Agilent  Technologies, Inc</td>
    </tr>
    <tr>
      <td>Jude     Medical, Inc, the US Government, Digi-Key Corporation, and certain other     <font color="blue">distributors</font></td>
    </tr>
    <tr>
      <td>In  fiscal 2006 we reduced our number of <font color="blue"><font color="blue">manufacture</font>rs</font>’     <font color="blue">representatives</font>,  <font color="blue">which increased</font> our <font color="blue">dependence on</font> our <font color="blue">North American     </font><font color="blue">distributors</font></td>
    </tr>
    <tr>
      <td>Orders from these large customers can be cancelled, postponed,     or <font color="blue">reduced without</font> cause, and the loss of any of these <font color="blue">customers could</font> have     a <font color="blue"><font color="blue">significant</font> impact on</font> our revenue and our <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">rely on government contracts</font> for a <font color="blue"><font color="blue">significant</font> percentage</font> of our revenue     and we <font color="blue">will <font color="blue">lose revenue</font></font> if <font color="blue">government funding</font> is reduced or eliminated</td>
    </tr>
    <tr>
      <td><font color="blue">US Government </font><font color="blue">contracts accounted</font> for the majority of our fiscal 2005     revenue, and although <font color="blue">US Government </font><font color="blue">contracts decreased as</font> a percentage of     our revenues in fiscal 2006, such contracts remain a <font color="blue">significant</font> portion of     our revenue</td>
    </tr>
    <tr>
      <td>A material decrease in <font color="blue">US Government </font><font color="blue">funding research</font> or     <font color="blue">dis<font color="blue">qualification</font> as</font> a vendor to the <font color="blue">US Government </font>for any <font color="blue">reason would</font>     <font color="blue">likely hamper future research</font> and <font color="blue"><font color="blue">development</font> activity as well as</font> related     revenue</td>
    </tr>
    <tr>
      <td>Failure to qualify as a small business under federal <font color="blue">regulations</font> could make     us ineligible for some government-funded research grants which could have a     <font color="blue"><font color="blue">significant</font> impact on</font> our revenue and our ability to make research and     <font color="blue">development</font> progress</td>
    </tr>
    <tr>
      <td>Federal <font color="blue">regulations</font> place a number of criteria for a business to be eligible     to compete for Small Business Innovation Research (SBIR) awards</td>
    </tr>
    <tr>
      <td><font color="blue">Those     </font>criteria include number of employees and <font color="blue">ownership structure</font></td>
    </tr>
    <tr>
      <td>While we     believe we meet the criteria, changes in our <font color="blue">ownership beyond</font> our control     could cause us to lose our <font color="blue">eligibility</font> to compete for SBIR awards, which in     turn could have a material adverse effect on our revenue, profits, and     research and <font color="blue">development</font> efforts</td>
    </tr>
    <tr>
      <td>9     ______________________________________________________________________         Our <font color="blue">backlog may</font> not result in <font color="blue">future revenue</font></td>
    </tr>
    <tr>
      <td>While we <font color="blue">evaluate each</font> order to determine <font color="blue">qualification</font> for inclusion in our     <font color="blue">firm backlog</font>, there can be no assurance that amounts included in our firm     <font color="blue">backlog ultimately will</font> result in <font color="blue">future revenue</font></td>
    </tr>
    <tr>
      <td>A reduction in our firm     <font color="blue">backlog during</font> any <font color="blue">particular period</font>, or the failure of our <font color="blue">firm backlog</font> to     result in <font color="blue">future revenue</font>, could harm our business and revenue</td>
    </tr>
    <tr>
      <td>We  face  an <font color="blue">uncertain economic environment</font> in our industry that could     <font color="blue">adversely affect</font> our business and <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>The semiconductor market, which is the <font color="blue">primary market</font> for our products, has     been subject to <font color="blue">sudden downturns</font> in the past</td>
    </tr>
    <tr>
      <td>Any <font color="blue">future downturn</font> in the     <font color="blue">economic environment would likely</font> have a material <font color="blue">adverse impact on</font> our     business and revenue</td>
    </tr>
    <tr>
      <td>Our <font color="blue">reputation could</font> be damaged and we <font color="blue">could <font color="blue">lose revenue</font></font> if we fail to meet     <font color="blue">technical challenges</font> required to produce <font color="blue">marketable products</font></td>
    </tr>
    <tr>
      <td>Our products use new <font color="blue">technology</font> and we are <font color="blue">continually researching</font> and     developing  product  designs  and <font color="blue">production processes</font></td>
    </tr>
    <tr>
      <td>Our production     processes require control of magnetic and other <font color="blue">parameters</font> that are not     required  in <font color="blue">conventional semiconductor processes</font></td>
    </tr>
    <tr>
      <td>If we are unable to     develop  <font color="blue">stable designs</font> and <font color="blue">production processes</font> we may not be able to     produce products that meet our customers’ <font color="blue">requirements</font>, which could cause     damage to our reputation and loss of revenue</td>
    </tr>
    <tr>
      <td>Our failure to <font color="blue">meet stringent customer technical <font color="blue">requirements</font> could</font> result     in the loss of <font color="blue">key customers</font> and <font color="blue">potentially reduce</font> our sales</td>
    </tr>
    <tr>
      <td>Some of our customers, including Avago (the company comprised of the former     Agilent Technologies, Inc</td>
    </tr>
    <tr>
      <td>Semiconductor Product Group), St</td>
    </tr>
    <tr>
      <td>Jude Medical,     and  Starkey Laboratories, have <font color="blue">stringent technical <font color="blue">requirements</font> which</font>     require our products to <font color="blue">pass certain test</font> and <font color="blue">qualification</font> criteria before     they are <font color="blue">accepted by such customers</font></td>
    </tr>
    <tr>
      <td>Failure to meet those criteria could     result in the loss of current sales revenue, customers and <font color="blue">future sales</font></td>
    </tr>
    <tr>
      <td>Our sensors are <font color="blue">incorporated</font> into <font color="blue">medical devices</font>, which could expose us to     a risk of <font color="blue">product <font color="blue">liability</font></font> claims and such claims <font color="blue"><font color="blue">could seriously</font> harm</font> our     business and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td><font color="blue">Certain  </font>of our sensor products are used in <font color="blue">medical devices</font>, including     cardiac <font color="blue">pacemakers</font> and implantable <font color="blue">cardioverter</font> <font color="blue">defibrillators</font> (ICDs) made     by St</td>
    </tr>
    <tr>
      <td>Jude Medical, <font color="blue">which help sustain human life</font></td>
    </tr>
    <tr>
      <td>We are <font color="blue">also marketing</font>     our <font color="blue">sensor <font color="blue">technology</font></font> to other <font color="blue"><font color="blue">manufacture</font>rs</font> of cardiac <font color="blue">pacemakers</font> and ICDs</td>
    </tr>
    <tr>
      <td><font color="blue">Although  </font>we have an <font color="blue"><font color="blue">indemnification</font> <font color="blue">agreement</font> with</font> a St</td>
    </tr>
    <tr>
      <td><font color="blue"><font color="blue">Jude Medical </font>    </font><font color="blue">company with provisions designed</font> to limit our exposure to <font color="blue">product <font color="blue">liability</font></font>     claims, there can be no assurance that we will not be subject to losses,     claims, damages, liabilities, or expenses resulting from bodily injury or     <font color="blue">property damage</font> arising from the <font color="blue">incorporation</font> of our sensors in products     sold by St</td>
    </tr>
    <tr>
      <td><font color="blue">Jude Medical </font>or others</td>
    </tr>
    <tr>
      <td>Existing or future laws or unfavorable     judicial  <font color="blue">decisions</font>  could  limit  or invalidate the provisions of our     <font color="blue">indemnification</font> <font color="blue">agreement</font>, or the <font color="blue">agreement</font> may not be enforceable in all     instances</td>
    </tr>
    <tr>
      <td>A successful <font color="blue">product <font color="blue">liability</font></font> claim could require us to pay, or     contribute to payment of, substantial damage awards, <font color="blue">which would</font> have a     <font color="blue">significant</font> negative effect on our business and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>Federal <font color="blue">legislation may</font> not <font color="blue">protect us against <font color="blue">liability</font></font> for the use of our     sensors in <font color="blue">medical devices</font> and a <font color="blue">successful <font color="blue">liability</font></font> claim <font color="blue">could seriously</font>     harm our business and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td><font color="blue">Although the Biomaterials Access Assurance Act </font>of 1998 may provide us some     protection against potential <font color="blue">liability</font> claims, that Act includes <font color="blue">significant</font>     <font color="blue">exceptions</font> to <font color="blue">supplier immunity provisions</font>, including <font color="blue">limitations</font> relating     to negligence or <font color="blue">willful misconduct</font></td>
    </tr>
    <tr>
      <td>A successful <font color="blue">product <font color="blue">liability</font></font> claim     could require us to pay, or contribute to payment of, substantial damage     awards, <font color="blue">which would</font> have a <font color="blue">significant</font> negative effect on our business and     <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>Any <font color="blue">product <font color="blue">liability</font></font> claim against us, with or without     merit, could result in costly <font color="blue">litigation</font>, divert the time, attention and     resources  of our <font color="blue">management</font> and have a material <font color="blue">adverse impact on</font> our     business</td>
    </tr>
    <tr>
      <td>Changes in the <font color="blue">interaction between</font> our sensors and our customers’ medical     <font color="blue">devices could</font> cause the <font color="blue">medical devices</font> to fail, exposing us to a risk of     product  <font color="blue">liability</font>  claims  that <font color="blue"><font color="blue">could seriously</font> harm</font> our business and     <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">sensors function</font> in <font color="blue">interaction with</font> our customers’ <font color="blue">medical devices</font></td>
    </tr>
    <tr>
      <td>Our     sensors are <font color="blue"><font color="blue">manufacture</font>d</font> to meet various electrical, magnetic, and other     specifications, but the <font color="blue">actual performance</font> of the products is <font color="blue">dependent on</font>     how  they  are used in the customers’ devices over the lifetime of the     devices</td>
    </tr>
    <tr>
      <td>This <font color="blue">interaction could</font> be <font color="blue">different than</font> expected for a number of     reasons</td>
    </tr>
    <tr>
      <td>Consequently, it is possible that <font color="blue">customers may</font> experience problems     with  their  <font color="blue">medical devices</font> that could require device recall or other     <font color="blue">corrective action</font>, where our <font color="blue">sensors met</font> the <font color="blue">specification at delivery</font>, and     for reasons that are not related primarily or at all to any <font color="blue">failure by</font> our     product to perform in <font color="blue">accordance with specifications</font></td>
    </tr>
    <tr>
      <td>It is possible that     our customers or our customers’ patients may assert that our sensors caused     or <font color="blue">contributed</font> to device failure where our product was not the primary cause     of the device <font color="blue">performance issue</font></td>
    </tr>
    <tr>
      <td>Any <font color="blue">malfunction</font> of our sensors in existing <font color="blue">medical devices</font> could lead to the     need to <font color="blue">recall devices incorporating</font> our <font color="blue">sensors from</font> the market, which may     be harmful to our reputation and cause a <font color="blue">significant</font> loss of revenue</td>
    </tr>
    <tr>
      <td>Any <font color="blue">malfunction</font> of our <font color="blue">sensors could lead</font> to the need to <font color="blue">recall existing</font>     <font color="blue">medical devices</font> incorporating our <font color="blue">sensors from</font> the market, which may be     harmful to our <font color="blue">reputation which</font> is <font color="blue">dependent on</font> product safety and efficacy</td>
    </tr>
    <tr>
      <td>Even if <font color="blue">assertions</font> that our sensors caused or <font color="blue">contributed</font> to device failure     do not lead to <font color="blue">product <font color="blue">liability</font></font> or contract claims, such <font color="blue">assertions</font> could                                           10     ______________________________________________________________________         harm  our reputation and our <font color="blue">customer relationships</font></td>
    </tr>
    <tr>
      <td>Any damage to our     reputation and/or the reputation of our products, or the reputation of our     customers  or  their  products  <font color="blue">could limit</font> the market for our and our     customers’ products and harm our results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>We may lose business and revenue if our <font color="blue">critical production equipment fails</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">production process relies on certain critical pieces</font> of equipment for     defining, depositing, and modifying the <font color="blue">magnetic properties</font> of very thin     <font color="blue">metal films</font></td>
    </tr>
    <tr>
      <td>While we have an in-house maintenance     staff, maintenance <font color="blue">agreement</font>s for <font color="blue">certain equipment</font>, some <font color="blue">critical spare</font>     parts, and back-ups for some of the equipment, we cannot be sure we could     repair or <font color="blue">replace critical manufacturing equipment</font> were it to fail</td>
    </tr>
    <tr>
      <td>If we are unable to deliver products we <font color="blue">face penalties</font>, including loss of     <font color="blue">certain exclusive manufacturing rights</font></td>
    </tr>
    <tr>
      <td><font color="blue">Our Agilent </font>supply <font color="blue">agreement</font> allows Agilent to gain rights to <font color="blue">manufacture</font>     couplers <font color="blue">based on</font> our <font color="blue">technology</font> if we are unable to deliver products on     time</td>
    </tr>
    <tr>
      <td>The imposition of this <font color="blue">penalty could</font> have a material <font color="blue">impact on future</font>     sales of our products</td>
    </tr>
    <tr>
      <td>Furthermore, <font color="blue">on reaching certain sales goals</font>, Agilent     <font color="blue">could gain exclusive rights</font> to <font color="blue">distribute certain couplers <font color="blue">based on</font></font> our     <font color="blue">technology</font>, which could reduce our <font color="blue">product sales</font> and <font color="blue">leave us partially</font> or     totally <font color="blue">dependent on</font> Agilent for future coupler sales</td>
    </tr>
    <tr>
      <td>Agilent may be able     to assign its <font color="blue">rights under</font> our <font color="blue">agreement</font> to Avago, the company comprised of     the former <font color="blue">Agilent Semiconductor Product Group</font></td>
    </tr>
    <tr>
      <td>The loss of <font color="blue">supply from</font> any of our key single-source wafer suppliers could     impact  our  ability to produce and deliver products and cause loss of     revenue</td>
    </tr>
    <tr>
      <td><font color="blue">Critical  </font>suppliers  include  our suppliers of <font color="blue">certain raw silicon</font> and     <font color="blue">semiconductor wafers</font> that are <font color="blue">incorporated</font> in our products</td>
    </tr>
    <tr>
      <td>We maintain     inventory of some critical wafers, but we have not identified or qualified     <font color="blue">alternate suppliers</font> for many of the wafers now being obtained from single     sources</td>
    </tr>
    <tr>
      <td>Any <font color="blue">supply interruption</font>s <font color="blue">could seriously</font> jeopardize our ability to     <font color="blue">provide products</font> that are critical to our business and <font color="blue">operations</font> and may     cause us to <font color="blue">lose revenue</font></td>
    </tr>
    <tr>
      <td>The loss of supply of any <font color="blue">critical chemicals</font> or <font color="blue">supplies could impact</font> our     ability to produce and deliver products and cause loss of revenue</td>
    </tr>
    <tr>
      <td>There are a number of <font color="blue">critical chemicals</font> and supplies that we require to     make products</td>
    </tr>
    <tr>
      <td>These include certain photoresists, polymers, metals, and     alloys</td>
    </tr>
    <tr>
      <td>We maintain inventory of <font color="blue">critical chemicals</font> and materials, but in     many cases we are <font color="blue">dependant on single sources</font>, and some of the materials     could  be  <font color="blue">discontinued</font>  by  their  suppliers  at any time</td>
    </tr>
    <tr>
      <td>Any supply     interruptions <font color="blue">could seriously</font> jeopardize our ability to <font color="blue">provide products</font>     that are critical to our business and <font color="blue">operations</font> and may cause us to lose     revenue</td>
    </tr>
    <tr>
      <td>The loss of <font color="blue">supply from</font> any of our single-source <font color="blue">packaging vendors</font> could     impact  our  ability to produce and deliver products and cause loss of     revenue</td>
    </tr>
    <tr>
      <td>We are <font color="blue">dependent on</font> our <font color="blue">packaging vendors</font> including Circuit Electronic     Industries  Public Co, Ltd</td>
    </tr>
    <tr>
      <td>(“CEI,” Ayutthaya, Thailand)</td>
    </tr>
    <tr>
      <td>Some of our     products use processes or tooling unique to a <font color="blue">particular packaging vendor</font>,     and it might be expensive, time-consuming, or impractical to convert to     another vendor in the event of a <font color="blue">supply interruption</font></td>
    </tr>
    <tr>
      <td>CEI had been operating     <font color="blue">under voluntary debt rehabilitation under</font> Thailand law</td>
    </tr>
    <tr>
      <td>We have potential     <font color="blue">alternate vendor</font>s in case CEI’s ability to serve our needs <font color="blue">becomes impaired</font>,     however  it  could  prove  expensive or time-consuming, or <font color="blue">technically</font>     <font color="blue">challenging</font> to convert to an <font color="blue">alternate vendor</font></td>
    </tr>
    <tr>
      <td>Any <font color="blue">supply interruption</font>s or     loss of inventory <font color="blue">could seriously</font> jeopardize our ability to <font color="blue">provide products</font>     that are critical to our business and <font color="blue">operations</font> and may cause us to lose     revenue</td>
    </tr>
    <tr>
      <td>Higher <font color="blue">packaging costs with</font> an <font color="blue">alternate vendor</font> could have a     <font color="blue"><font color="blue">significant</font> impact on</font> our <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>Because we are <font color="blue">significant</font>ly smaller than the majority of our <font color="blue">competitors</font>,     we may lack the <font color="blue">financial resources</font> needed to increase our market share and     <font color="blue">future revenue</font></td>
    </tr>
    <tr>
      <td>Our  known <font color="blue">competitors</font> and potential <font color="blue">competitors</font> include Avago, Analog     Devices, Inc, Fairchild Semiconductor International, Fujitsu Limited,     Grandis, Inc, Hermetic Switch, Inc, IBM Corporation, Infineon Technologies     AG, Intel Corporation, Linear Technology Inc, Macronix International Co,     Ltd, Maxim Integrated Products, Inc, Meder Electronic AG, Memscap SA,     Nantero, Inc,  NEC  Corporation,  Ovonyx, Inc, Ramtron International     Corporation,  Silicon Laboratories, Inc, Simtek Corporation, Spintec,     Spintron,  Texas  Instruments Inc, Thin Film Electronics ASA, Toshiba     Corporation, Vishay Inter<font color="blue">technology</font>, and others</td>
    </tr>
    <tr>
      <td>We believe that we face     <font color="blue">particularly aggressive <font color="blue">competition</font></font> in our coupler business, and we believe     that our <font color="blue">competition</font> is <font color="blue">increasing as</font> the <font color="blue">technology</font> matures</td>
    </tr>
    <tr>
      <td>This has meant     more  <font color="blue">competitors</font>  and  more <font color="blue">severe pricing pressure</font></td>
    </tr>
    <tr>
      <td>Furthermore, our     <font color="blue">competitors</font> are narrowing or <font color="blue">eliminating performance <font color="blue">advantages</font></font> we may have     had</td>
    </tr>
    <tr>
      <td>We expect these trends to continue, and our <font color="blue">future <font color="blue">competitive</font>ness will</font>     <font color="blue">depend on</font> our ability to develop <font color="blue">new products</font> and reduce our <font color="blue">product costs</font></td>
    </tr>
    <tr>
      <td>Most of our <font color="blue">competitors</font> and potential <font color="blue">competitors</font> are established companies     that  have  <font color="blue">significant</font>ly  greater financial, technical, and marketing     resources than us</td>
    </tr>
    <tr>
      <td>While we believe that our products have important                                           11     ______________________________________________________________________         <font color="blue">competitive</font>  <font color="blue">advantages</font>, our <font color="blue">competitors</font> may succeed in developing and     <font color="blue">marketing products</font> that perform better or are <font color="blue">less expensive than ours</font>, or     that would render our products and <font color="blue">technology</font> obsolete or non<font color="blue">competitive</font></td>
    </tr>
    <tr>
      <td>Our business may suffer because we have limited <font color="blue">influence over</font> the rate of     adoption of our <font color="blue">technology</font>, and MRAM <font color="blue">technology</font> may not <font color="blue">build into</font> a large     or <font color="blue">significant</font> market</td>
    </tr>
    <tr>
      <td>A <font color="blue">significant</font> portion of our <font color="blue">future revenue</font> and profits is <font color="blue">dependent on</font> our     current  and  future  licensees  introducing MRAM products</td>
    </tr>
    <tr>
      <td><font color="blue">Production     </font><font color="blue">difficulties</font>,  technical  barriers, high production costs, poor market     reception or other problems, almost all of which are outside our control,     <font color="blue">could prevent</font> the <font color="blue">deployment</font> of MRAM or limit its market potential</td>
    </tr>
    <tr>
      <td>In     addition, our <font color="blue">licensees may</font> have other priorities that <font color="blue">detract attention</font> and     resources  from  <font color="blue">introduction</font>  of  MRAM <font color="blue">products using</font> our <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>Furthermore, competing <font color="blue">technologies</font> <font color="blue">could prevent</font> or supplant MRAM from     becoming an important memory <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>Our license <font color="blue">agreement</font>s include revenue minimums and royalty limits, which     could  limit  the  total  amount  of revenue we can <font color="blue">derive under</font> these     <font color="blue">agreement</font>s</td>
    </tr>
    <tr>
      <td>Our existing license <font color="blue">agreement</font>s do not provide for us to receive royalties     <font color="blue">until revenue minimums</font> are <font color="blue">met by licensees</font></td>
    </tr>
    <tr>
      <td>In addition, some of these     <font color="blue">agreement</font>s  place <font color="blue">limits on future royalty</font> and <font color="blue">license payments</font></td>
    </tr>
    <tr>
      <td><font color="blue">These     </font><font color="blue"><font color="blue">provisions could</font> substantially delay</font> our <font color="blue">potential revenue</font> and <font color="blue">profits from</font>     these <font color="blue">licensing arrangements</font> and <font color="blue">could limit</font> the <font color="blue">total amount</font> of revenue     that we can <font color="blue">derive under</font> these license <font color="blue">agreement</font>s</td>
    </tr>
    <tr>
      <td>Such <font color="blue">provisions could</font>     limit our potential MRAM revenue and profits under existing <font color="blue">agreement</font>s</td>
    </tr>
    <tr>
      <td>Our <font color="blue">licensees may</font> not be able to make <font color="blue">commercially viable</font> MRAMs, <font color="blue">which would</font>     limit our <font color="blue">revenue from</font> MRAM and likely cause our stock price to decline</td>
    </tr>
    <tr>
      <td>MRAM  is  a  new <font color="blue">technology</font>, and we are almost completely <font color="blue">dependent on</font>     licensees to convert our <font color="blue"><font color="blue">intellectual</font> property</font> into <font color="blue">commercially viable</font>     MRAM While our licensees have made samples, there may be technical and     <font color="blue">manufacturing issues</font> to be resolved before <font color="blue">commercially viable</font> devices can     be produced, and these <font color="blue">problems may never successfully</font> be solved</td>
    </tr>
    <tr>
      <td>Our future business may suffer because we may not be able to consummate     <font color="blue">additional</font> MRAM license <font color="blue">agreement</font>s</td>
    </tr>
    <tr>
      <td>Although there are <font color="blue">potential licensees</font> for our MRAM <font color="blue"><font color="blue">intellectual</font> property</font> in     addition  to our <font color="blue">current licensees</font>, we may never be able to consummate     <font color="blue">additional</font> license <font color="blue">agreement</font>s</td>
    </tr>
    <tr>
      <td><font color="blue">Potential </font>licensees for our MRAM <font color="blue">intellectual</font>     <font color="blue">property might</font> not be <font color="blue">interested unless</font> and until the <font color="blue">commercial viability</font>     of the <font color="blue">technology</font> is <font color="blue">demonstrated</font></td>
    </tr>
    <tr>
      <td><font color="blue">Potential </font><font color="blue"><font color="blue">licensees could</font> also use</font> their     own or a third party’s MRAM <font color="blue"><font color="blue">intellectual</font> property</font> rather than ours</td>
    </tr>
    <tr>
      <td>In     addition, our existing <font color="blue">agreement</font>s place <font color="blue">restrictions on future license</font>     <font color="blue">agreement</font>s</td>
    </tr>
    <tr>
      <td>Specifically, one of our <font color="blue">agreement</font>s allows one of our licensees     to <font color="blue">approve licenses with certain</font> other <font color="blue">potential licensees</font></td>
    </tr>
    <tr>
      <td>Each of these     <font color="blue">limitations</font> could hinder our ability to consummate <font color="blue">additional</font> MRAM license     <font color="blue">agreement</font>s</td>
    </tr>
    <tr>
      <td>We will not receive royalties if our licensees do not use our <font color="blue">intellectual</font>     property</td>
    </tr>
    <tr>
      <td>Our license <font color="blue">agreement</font>s do not require our licensees to use our <font color="blue">intellectual</font>     property</td>
    </tr>
    <tr>
      <td>Although we believe, <font color="blue">based on</font> their <font color="blue">public disclosures</font>, that     devices <font color="blue"><font color="blue">Freescale </font>and Motorola </font>have <font color="blue">described use</font> our <font color="blue"><font color="blue">intellectual</font> property</font>     at least to some extent, our <font color="blue"><font color="blue">licensees could</font> circumvent</font> or <font color="blue">find alternatives</font>     to all or some of our <font color="blue">technology</font>, and our license <font color="blue">agreement</font>s require royalty     payments  only if our <font color="blue">licensees use</font> our <font color="blue"><font color="blue">intellectual</font> property</font> in their     devices</td>
    </tr>
    <tr>
      <td>It is possible that our <font color="blue">licensees might</font> make MRAM <font color="blue">devices without</font>     using our <font color="blue">technology</font> or <font color="blue">infringing on</font> our patents, and we would not receive     <font color="blue">royalties on such devices</font></td>
    </tr>
    <tr>
      <td>We  may not be able to enforce our <font color="blue"><font color="blue">intellectual</font> property</font> rights or our     <font color="blue">technology</font> may prove to <font color="blue">infringe upon patents</font> or rights owned by others,     <font color="blue">which may prevent</font> the future sale of our products or increase the cost of     such sales</td>
    </tr>
    <tr>
      <td>We protect our <font color="blue">proprietary</font> <font color="blue">technology</font> and <font color="blue"><font color="blue">intellectual</font> property</font> by seeking     patents,  <font color="blue">trademarks</font>, and <font color="blue">copyrights</font>, and by maintaining <font color="blue">trade secrets</font>     through entering into confidentiality <font color="blue">agreement</font>s with employees, suppliers,     customers, and <font color="blue">prospective customers depending on</font> the <font color="blue">circumstances</font></td>
    </tr>
    <tr>
      <td>We hold     patents or are the licensee of others owning patented <font color="blue">technology</font> covering     <font color="blue"><font color="blue">certain as</font>pects</font> of our sensor, coupler, and MRAM <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>These patent     rights  may  be  challenged,  rendered  unenforceable,  invalidated or     <font color="blue">circumvented</font></td>
    </tr>
    <tr>
      <td>In  addition, rights granted under the patents or under     licensing <font color="blue">agreement</font>s may not provide a <font color="blue">competitive</font> advantage to us</td>
    </tr>
    <tr>
      <td>At least     <font color="blue">several potential</font> MRAM <font color="blue">competitors</font> have <font color="blue">described designs</font> that we believe     <font color="blue">would infringe on</font> our patents if <font color="blue">such designs</font> were to be <font color="blue">commercialized</font></td>
    </tr>
    <tr>
      <td>Further, <font color="blue">others may independently</font> develop similar, superior, or parallel     <font color="blue">technologies</font> to any <font color="blue">technology</font> developed by us, or our <font color="blue">technology</font> may prove     to <font color="blue">infringe upon patents</font> or rights owned by others</td>
    </tr>
    <tr>
      <td>Thus the patents held by     or licensed to us may not afford us any <font color="blue">meaningful</font> <font color="blue">competitive</font> advantage</td>
    </tr>
    <tr>
      <td>Also, our confidentiality <font color="blue">agreement</font>s may not provide <font color="blue">meaningful</font> protection     of our <font color="blue">proprietary</font> information</td>
    </tr>
    <tr>
      <td>Our <font color="blue">inability</font> to maintain our <font color="blue">proprietary</font>     <font color="blue">rights could</font> have a material adverse effect on our business, financial     condition and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Our future business may suffer if we are unable to enforce our <font color="blue">intellectual</font>     <font color="blue">property rights with existing licensees</font></td>
    </tr>
    <tr>
      <td>Our existing license <font color="blue">agreement</font>s have not <font color="blue">generated royalties</font> and may never     <font color="blue">become active</font> or generate <font color="blue">significant</font> royalties</td>
    </tr>
    <tr>
      <td>Furthermore, our success in     enforcing our <font color="blue"><font color="blue">intellectual</font> property</font> rights may be <font color="blue">dependent on</font> our ability     to enforce                                           12     ______________________________________________________________________         our  contract  rights  under existing license <font color="blue">agreement</font>s</td>
    </tr>
    <tr>
      <td>Our existing     <font color="blue">licensees could</font> claim <font color="blue">without merit</font> that they do not use our <font color="blue">intellectual</font>     property or claim that one or more of our patents are invalid</td>
    </tr>
    <tr>
      <td>In 2000 we     were forced to resort to <font color="blue">litigation</font> to enforce our <font color="blue"><font color="blue">intellectual</font> property</font>     rights with Motorola, and we plan to continue to <font color="blue">vigorously</font> defend our     <font color="blue"><font color="blue">intellectual</font> property</font> rights</td>
    </tr>
    <tr>
      <td>Our limited <font color="blue">capital resources could put us at</font>     a <font color="blue">disadvantage</font> if we take <font color="blue">legal action</font> to enforce our <font color="blue"><font color="blue">intellectual</font> property</font>     rights</td>
    </tr>
    <tr>
      <td>We  may  not  be able to negotiate a new MRAM licensing <font color="blue">agreement</font> with     Freescale</td>
    </tr>
    <tr>
      <td><font color="blue">Our Patent License Option Agreement </font>with Motorola provided for <font color="blue">termination</font>     <font color="blue">December </font>31, 2005 or on the date Motorola <font color="blue">ceases manufacturing</font> <font color="blue"><font color="blue">MRAM Products </font>    </font>whichever is later</td>
    </tr>
    <tr>
      <td>We believe such a <font color="blue">termination</font> is likely to have occurred     as  a  result  of Motorola <font color="blue">apparently</font> having eliminated its ability to     <font color="blue">manufacture</font> <font color="blue">MRAM Products </font>through its spinoff of Freescale</td>
    </tr>
    <tr>
      <td>We are free to     negotiate a new <font color="blue">agreement</font> with <font color="blue">Freescale </font>or an <font color="blue">assignment</font> of the Motorola     Patent License Option Agreement to Freescale, but would do so only with     <font color="blue">amendments</font>  thereto</td>
    </tr>
    <tr>
      <td>There can be no assurance, however, that any such     <font color="blue">agreement</font> can be <font color="blue">reached with</font> Freescale, or that any such <font color="blue">agreement</font> with     <font color="blue">Freescale </font>would be on more favorable terms to NVE than the present <font color="blue">agreement</font>     with Motorola, or that NVE would receive any <font color="blue">value under</font> the existing Patent     License Option Agreement or any <font color="blue">value under</font> any such further <font color="blue">agreement</font> with     Freescale</td>
    </tr>
    <tr>
      <td>Our business <font color="blue">success may</font> be <font color="blue">adversely affect</font>ed if we are unable to attract     and retain highly qualified <font color="blue">management</font> and <font color="blue">technical employees</font></td>
    </tr>
    <tr>
      <td>We have no employment <font color="blue">agreement</font>s with any of our <font color="blue">management</font> other than our     Chief Executive Officer and Chief Financial Officer, and have no key-person     insurance covering employees</td>
    </tr>
    <tr>
      <td><font color="blue">Competition </font>for highly qualified <font color="blue">management</font>     and technical personnel is <font color="blue">generally</font> intense and we may not be able to     attract and retain the personnel <font color="blue">necessary</font> for the <font color="blue">development</font> and operation     of our business</td>
    </tr>
    <tr>
      <td>The loss of the services of <font color="blue">key personnel could</font> have a     material adverse effect on our business, <font color="blue">financial condition</font> and results of     <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>While our Chief Technology Officer, Dr</td>
    </tr>
    <tr>
      <td>Daughton, no longer     <font color="blue">generally</font>  works  full time, he still makes his technical and contract     <font color="blue">development</font> expertise available to us</td>
    </tr>
    <tr>
      <td>If that <font color="blue">arrangement terminates</font>, we     may not be able to replace his expertise</td>
    </tr>
    <tr>
      <td>While we believe that we currently have <font color="blue">adequate internal control over</font>     financial reporting in place, in the future our <font color="blue">management</font> will be required     to evaluate our <font color="blue">internal control over financial</font> reporting under Section 404     of  the  Sarbanes-Oxley  act of 2002 and any adverse results from such     <font color="blue">evaluation could</font> result in a loss of <font color="blue">investor confidence</font> in our financial     reports and have an <font color="blue">adverse affect on</font> our financial results and the market     price of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>As  required by Section 404 of the Sarbanes-Oxley Act of 2002, <font color="blue">the SEC     </font><font color="blue">adopted rules</font> requiring <font color="blue">each public company</font> to include a <font color="blue">management</font> report     assessing the <font color="blue">effectiveness</font> of its <font color="blue">internal control over financial</font> reporting     in <font color="blue">Annual Reports </font>on Form 10-KSB or 10-K, and the <font color="blue">independent registered</font>     public accounting firm auditing such company’s financial statements must     attest to and report on <font color="blue">management</font>’s assessment of the <font color="blue">effectiveness</font> of the     <font color="blue">internal control over financial</font> reporting</td>
    </tr>
    <tr>
      <td>This <font color="blue">requirement will apply</font> to     our <font color="blue">Annual Report </font>for the <font color="blue">fiscal year</font> ending March 31, 2007 if we meet the     tests for being an “Accelerated Filer” as of <font color="blue">September </font>30, 2006</td>
    </tr>
    <tr>
      <td>If we are     not  deemed  to  be  an  <font color="blue">Accelerated Filer </font>on that date, under current     <font color="blue">regulations</font> we will be required to <font color="blue">comply with</font> Section 404 in our Annual     Report  for  the <font color="blue">fiscal year</font> ending March 31, 2008</td>
    </tr>
    <tr>
      <td>While we currently     anticipate  being able to fully implement the <font color="blue">requirements</font> relating to     <font color="blue">compliance with</font> Section 404 in a <font color="blue">timely fashion</font>, we cannot be <font color="blue">certain as</font> to     the timing of <font color="blue">completion</font> of our evaluation, testing and <font color="blue">remediation actions</font>     or the impact of <font color="blue">such activities on</font> our <font color="blue">operations</font> due in large part to the     lack  of  <font color="blue">precedent available by which</font> to measure <font color="blue">compliance with</font> such     <font color="blue">requirements</font></td>
    </tr>
    <tr>
      <td>If  we  are  not  able to implement the <font color="blue">requirements</font> of     Section 404 in a <font color="blue">timely manner</font> or with adequate compliance, investors could     <font color="blue">lose confidence</font> in the re<font color="blue">liability</font> of our financial statements, which could     result in a decrease in the <font color="blue">market price</font> of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>In addition,     to  the extent we or our <font color="blue">independent registered</font> public accounting firm     identify a <font color="blue">significant</font> deficiency in our <font color="blue">internal control over financial</font>     reporting, the resources and costs required to <font color="blue">remediate such deficiency</font>     could have a material <font color="blue">adverse impact on</font> our future results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>We are <font color="blue">presently involved</font> in class action <font color="blue">litigation</font></td>
    </tr>
    <tr>
      <td><font color="blue">On <font color="blue">February </font></font>10, 2006 a lawsuit was <font color="blue">filed against</font> NVE and certain of its     current and former executive officers and <font color="blue">directors</font> in the US District     Court for the District of Minnesota by an individual <font color="blue">shareholder seeking</font> to     represent a class of purchasers of our <font color="blue">common stock</font> during the <font color="blue">period from</font>     May 22, 2003 through <font color="blue">February </font>11, 2005</td>
    </tr>
    <tr>
      <td>On March 6 and March 7, 2006, two     <font color="blue">additional</font> lawsuits were filed in the same court by two <font color="blue">additional</font> NVE     <font color="blue">shareholders</font>, with the <font color="blue">same proposed</font> class period, purporting to represent     the same class</td>
    </tr>
    <tr>
      <td>All of the <font color="blue">complaints</font> make similar <font color="blue">allegations</font> that the     <font color="blue">defendants violated</font> the <font color="blue">Securities Exchange Act </font>of 1934 by issuing material     <font color="blue">misrepresentations</font>  <font color="blue">concerning</font>  NVE’s  projected  revenues and product     <font color="blue">technology</font>, which artificially inflated the <font color="blue">market price</font> of our common     stock</td>
    </tr>
    <tr>
      <td>Two related <font color="blue">actions brought by</font> individual <font color="blue">shareholders</font> who seek to     represent NVE <font color="blue">derivatively</font> have been filed in Hennepin County District     Court</td>
    </tr>
    <tr>
      <td>Those lawsuits allege that <font color="blue">certain officers</font> and <font color="blue">directors</font> violated     their <font color="blue">fiduciary duties</font> to the company</td>
    </tr>
    <tr>
      <td>We believe the lawsuits are wholly     <font color="blue">without merit</font> and intend to <font color="blue">vigorously</font> defend the actions</td>
    </tr>
    <tr>
      <td>We have incurred     and expect to continue to <font color="blue">incur legal expenses</font> related to these lawsuits</td>
    </tr>
    <tr>
      <td><font color="blue">Although  </font>insurance may cover a portion of any judgments, if we do not     prevail in these lawsuits we may be required to pay substantial amounts     which  could  have  a material <font color="blue">adverse impact on</font> our future results of     operation and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>13     ______________________________________________________________________         Risks Related to Buying Our Stock         Our stock has been more <font color="blue">volatile than</font> other <font color="blue">technology</font> sector stocks</td>
    </tr>
    <tr>
      <td>The  market  price  of  our  common  stock has experienced <font color="blue">significant</font>     <font color="blue">fluctuations</font> and <font color="blue">may continue</font> to fluctuate in the future</td>
    </tr>
    <tr>
      <td>We believe these     <font color="blue">fluctuations</font> have <font color="blue">been greater on</font> a <font color="blue">percentage basis than</font> other <font color="blue">technology</font>     sector stocks</td>
    </tr>
    <tr>
      <td>Our  stock  may be subject to <font color="blue">volatility</font> because it is not listed on a     <font color="blue">national market</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">common stock</font> is traded on the NASDAQ Capital Market (formerly known as     the NASDAQ SmallCap Market), which has <font color="blue">less daily trading volume on average</font>     than the <font color="blue">average trading market</font> for <font color="blue">companies quoted on</font> other NASDAQ market     tiers or the <font color="blue">New York Stock Exchange</font></td>
    </tr>
    <tr>
      <td>A <font color="blue">public trading market</font> having the     desired <font color="blue">characteristics</font> of depth, liquidity and <font color="blue">orderliness depends on</font> the     presence in the marketplace of <font color="blue">willing buyers</font> and sellers of our common     stock at any given time</td>
    </tr>
    <tr>
      <td>This <font color="blue">presence depends on</font> the individual <font color="blue">decisions</font>     of investors and <font color="blue">general economic</font> and <font color="blue">market conditions over which</font> we have     no control</td>
    </tr>
    <tr>
      <td>The price of our <font color="blue">common stock</font> may be <font color="blue">adversely affect</font>ed by <font color="blue">significant</font> price     <font color="blue">fluctuations</font>  due to a number of factors, many of which are beyond our     control</td>
    </tr>
    <tr>
      <td>Our <font color="blue">stock price declined</font> in each of the past two <font color="blue">fiscal year</font>s, and could     continue  to  decline</td>
    </tr>
    <tr>
      <td>The  market  price  of our <font color="blue">common stock</font> may be     <font color="blue">significant</font>ly  affected  by many factors, some of which are beyond our     control, including:         •      <font color="blue">technological innovations by us</font>, our licensees, or our <font color="blue">competitors</font>;         •      the <font color="blue">announcement</font> of <font color="blue">new products</font>, product enhancements, contracts, or     license <font color="blue">agreement</font>s by us, our licensees, or our <font color="blue">competitors</font>;         •      changes in <font color="blue">requirements</font> or demands for our products;         •      changes in prices of our products and services or our <font color="blue">competitors</font>’     products and services;         •      <font color="blue">quarterly variations</font> in our operating results;         •      changes in our revenue and <font color="blue">revenue growth rates</font>;         •       changes  in  revenue  estimates, earnings estimates, or market     <font color="blue">projections</font>  by  market  analysts, speculation in the press or analyst     <font color="blue">community</font>;         •      short selling and covering of short positions in our stock; and         •      <font color="blue">general market conditions</font> or <font color="blue">market conditions specific</font> to particular     <font color="blue">industries</font></td>
    </tr>
  </tbody>
</table>